Skip to main content Back to Top
Advertisement

11/25/2019

Ciprofloxacin Oral Suspension

Products Affected - Description

    • Ciprofloxacin oral powder for suspension, Lupin, 250 mg/5 mL, 100 mL bottle, NDC 68180-0392-01
    • Ciprofloxacin oral powder for suspension, Lupin, 500 mg/5 mL, 100 mL bottle, NDC 68180-0393-01

Reason for the Shortage

    • Lupin has ciprofloxacin oral powder for suspension on long term back order and the company has no plans to reintroduce the product.
    • Bayer has Cipro oral suspension available.

Available Products

    • Cipro oral powder for suspension, Bayer, 250 mg/5 mL, 100 mL bottle, NDC 50419-0777-01
    • Cipro oral powder for suspension, Bayer, 500 mg/5 mL, 100 mL bottle, NDC 50419-0773-01

Estimated Resupply Dates

    • Lupin has ciprofloxacin oral suspension on long-term back order and the company cannot estimate a release date.
    • Bayer has Cipro oral suspension readily available.

Updated

Updated November 25, 2019 by Megan Dryer, PharmD. Created August 24, 2016 by Leslie Jensen, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.